Short Interest in Jaguar Health, Inc. (NASDAQ:JAGX) Drops By 27.1%

Jaguar Health, Inc. (NASDAQ:JAGX) was the recipient of a large decrease in short interest during the month of April. As of April 15th, there was short interest totalling 14,360,000 shares, a decrease of 27.1% from the March 31st total of 19,710,000 shares. Based on an average daily trading volume, of 59,870,000 shares, the short-interest ratio is presently 0.2 days.

Jaguar Health Trading Up 5.9 %

NASDAQ JAGX traded up $0.01 during trading hours on Friday, reaching $0.18. 43,999,118 shares of the stock traded hands, compared to its average volume of 84,090,512. The stock has a 50 day simple moving average of $0.10 and a two-hundred day simple moving average of $0.18. Jaguar Health has a 1 year low of $0.05 and a 1 year high of $1.22. The company has a current ratio of 2.00, a quick ratio of 1.34 and a debt-to-equity ratio of 6.33.

Wall Street Analyst Weigh In

Separately, StockNews.com initiated coverage on shares of Jaguar Health in a report on Monday, April 22nd. They issued a “sell” rating on the stock.

About Jaguar Health

Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.